E-resources
-
Suekane, Shigetaka; Yutani, Shigeru; Yamada, Akira; Sasada, Tetsuro; Matsueda, Satoko; Takamori, Shinzo; Toh, Uhi; Kawano, Kouichiro; Yoshiyama, Koichi; Sakamoto, Shinjiro; Sugawara, Shunichi; Komatsu, Nobukazu; Yamada, Teppei; Naito, Masayasu; Terasaki, Mizuhiko; Mine, Takashi; Itoh, Kyogo; Shichijo, Shigeki; Noguchi, Masanori
International journal of oncology, 06/2020, Volume: 56, Issue: 6Journal Article
Peptide‑based cancer vaccines have failed to provide sufficient clinical benefits in order to be approved in clinical trials since the 1990s. To understand the mechanisms underlying this failure, the present study investigated biomarkers associated with the lower overall survival (OS) among 2,588 patients receiving personalized peptide vaccination (PPV). Survival data were obtained from a database of 2,588 cancer patients including 399 patients with lung, 354 with prostate and 344 with colon cancer. They entered into phase II clinical trials of PPV in which 2 to 4 of 31 warehouse peptides were selected for vaccination on an individual patient basis based on human leukocyte antigen (HLA) class IA‑types and pre‑existing peptide‑specific IgG levels. Higher pre‑vaccination neutrophil, monocyte and platelet counts, and lower pre‑vaccination lymphocyte and red blood cell counts were inversely associated with OS, with higher sensitivities in the proportions of neutrophils and lymphocytes, respectively. The most potent unfavorable and favorable factors for OS were the median percentage of neutrophils (≥64.8%) or percentage of lymphocytes (≥25.1%) with correlation coefficients (R2) of 0.98 and 0.92, respectively. Higher pre‑vaccination levels of c‑reactive protein and other inflammatory soluble factors were inversely associated with OS. Pre‑vaccination peptide‑specific immunity levels had no effect on OS, although lower immune boosting levels were inversely associated with OS. None of the 31 peptides was inversely associated with OS, although a few peptides were positively associated with it. On the whole, the findings of the present study suggested that pre‑vaccination inflammatory signatures, but not those of post‑vaccination immune induction, were associated with lower clinical benefits of PPV.
Author
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.